These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 3002919)
1. Adjuvant therapy in mixed mullerian tumors of the uterus. Kohorn EI; Schwartz PE; Chambers JT; Peschel RE; Kapp DS; Merino M Gynecol Oncol; 1986 Feb; 23(2):212-21. PubMed ID: 3002919 [TBL] [Abstract][Full Text] [Related]
2. Effects of irradiation on mixed müllerian tumors of the uterus. Perez CA; Askin F; Baglan RJ; Kao MS; Kraus FT; Perez BM; Williams CF; Weiss D Cancer; 1979 Apr; 43(4):1274-84. PubMed ID: 221087 [TBL] [Abstract][Full Text] [Related]
3. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy. Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561 [TBL] [Abstract][Full Text] [Related]
4. [Malignant mesodermal mixed tumor of the uterus--a study of 37 cases]. Zhang WH Zhonghua Zhong Liu Za Zhi; 1991 Sep; 13(5):378-80. PubMed ID: 1664319 [TBL] [Abstract][Full Text] [Related]
5. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435 [TBL] [Abstract][Full Text] [Related]
6. Patterns of recurrence in malignant mixed müllerian tumor of the uterus. Spanos WJ; Peters LJ; Oswald MJ Cancer; 1986 Jan; 57(1):155-9. PubMed ID: 3000571 [TBL] [Abstract][Full Text] [Related]
8. Mixed müllerian tumours of the uterus--prognostic factors: a clinical and histopathologic study of 147 cases. Larson B; Silfverswärd C; Nilsson B; Pettersson F Radiother Oncol; 1990 Feb; 17(2):123-32. PubMed ID: 2157241 [TBL] [Abstract][Full Text] [Related]
9. Stage I uterine adenosarcoma: a report of six cases. Baker TR; Piver MS; Lele SB; Tsukada Y J Surg Oncol; 1988 Feb; 37(2):128-32. PubMed ID: 2830437 [TBL] [Abstract][Full Text] [Related]
10. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma. Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235 [TBL] [Abstract][Full Text] [Related]
11. Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Kelly MG; O'malley DM; Hui P; McAlpine J; Yu H; Rutherford TJ; Azodi M; Schwartz PE Gynecol Oncol; 2005 Sep; 98(3):353-9. PubMed ID: 16005947 [TBL] [Abstract][Full Text] [Related]
12. Cisplatin and adriamycin combination chemotherapy for uterine stromal sarcomas and mixed mesodermal tumors. Peters WA; Rivkin SE; Smith MR; Tesh DE Gynecol Oncol; 1989 Sep; 34(3):323-7. PubMed ID: 2767523 [TBL] [Abstract][Full Text] [Related]
13. Patterns of relapse in stage I-II uterine papillary serous carcinoma treated with adjuvant intravaginal radiation (IVRT) with or without chemotherapy. Desai NB; Kiess AP; Kollmeier MA; Abu-Rustum NR; Makker V; Barakat RR; Alektiar KM Gynecol Oncol; 2013 Dec; 131(3):604-8. PubMed ID: 24055615 [TBL] [Abstract][Full Text] [Related]
14. Mixed Mullerian tumors of the uterus: clinical and pathologic correlations. Lotocki R; Rosenshein NB; Grumbine F; Dillon M; Parmley T; Woodruff JD Int J Gynaecol Obstet; 1982 Jun; 20(3):237-43. PubMed ID: 6127253 [TBL] [Abstract][Full Text] [Related]
15. Management of malignant, mixed mesodermal tumors of the uterus. Podczaski ES; Woomert CA; Stevens CW; Manetta A; Larson JE; Zaino RJ; Mortel R Gynecol Oncol; 1989 Feb; 32(2):240-4. PubMed ID: 2536000 [TBL] [Abstract][Full Text] [Related]
16. Malignant mixed mullerian tumors of the ovary. An analysis of two long-term survivors. Dass KK; Biscotti CV; Webster K; Saxton JP Am J Clin Oncol; 1993 Aug; 16(4):346-9. PubMed ID: 8392289 [TBL] [Abstract][Full Text] [Related]
17. Prognostic features of sarcomas and mixed tumors of the endometrium. Peters WA; Kumar NB; Fleming WP; Morley GW Obstet Gynecol; 1984 Apr; 63(4):550-6. PubMed ID: 6322081 [TBL] [Abstract][Full Text] [Related]
18. The Impact of Adjuvant Therapy on Survival and Recurrence Patterns in Women With Early-Stage Uterine Carcinosarcoma: A Multi-institutional Study. Guttmann DM; Li H; Sevak P; Grover S; Jacobson G; Feldman A; Rubin S; Chu C; Bhatia S; Elshaikh MA; Lin LL Int J Gynecol Cancer; 2016 Jan; 26(1):141-8. PubMed ID: 26509850 [TBL] [Abstract][Full Text] [Related]
19. Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed müllerian tumors of the uterus. Wong L; See HT; Khoo-Tan HS; Low JS; Ng WT; Low JJ Int J Gynecol Cancer; 2006; 16(3):1364-9. PubMed ID: 16803531 [TBL] [Abstract][Full Text] [Related]
20. Carcinosarcomas and mixed Müllerian tumors of the fallopian tube. Muntz HG; Rutgers JL; Tarraza HM; Fuller AF Gynecol Oncol; 1989 Jul; 34(1):109-15. PubMed ID: 2544489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]